Jeremy Green Net Worth & Insider Trades

Jeremy Green Neoleukin Therapeutics, Inc

As of April 6, 2020

What is Jeremy Green's Net Worth?

The current estimated net worth of Neoleukin Therapeutics, Inc's Jeremy Green is estimated to be about $1.27B . Jeremy Green owns about 4,041,211 units of Neoleukin Therapeutics, Inc common stock. Recently at Neoleukin Therapeutics, Inc, Jeremy Green has sold an estimated value of $220.15K worth.

What is Jeremy Green's Past Insider Trading?

Jeremy Green's largest purchase order was 194,300 units , worth over $2.01M on April 6, 2020. Jeremy Green's largest sale order was 19,668 units , worth over $220.15K on April 6, 2020. In total, Jeremy Green has made about 1 transaction recently at Neoleukin Therapeutics, Inc. Jeremy Green usually trades in April, with the busiest year in 2020.

Redmile Group LLC, Jeremy Green

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jeremy Green's' Mailing Address?

  • Mailing address is One Letterman Drive, Building D Suite D3-300 San Francisco CA 94129 CA

Neoleukin Therapeutics, Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Jonathan DrachmanJonathan Drachman 2020 $4,468,538 $4,468,538 $4,468,538 - $4,468,538
Jonathan DrachmanJonathan Drachman 2019 $3,823,038 $3,823,038 $3,823,038 - $3,823,038
Robert Ho 2020 $2,654,271 $2,654,271 $2,654,271 - $2,654,271
Holly Vance 2020 $2,091,819 $2,091,819 $2,091,819 - $2,091,819
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1404644/000119312521102235/d129921ddef14a.htm

What are Neoleukin Therapeutics, Inc's Past Insider Trades?

Neoleukin Therapeutics, Inc's most recent insider trade came on August 12, 2022 by Sean Smith who sold 1,655 units worth $1.64K . In the last 14 years, insiders at Neoleukin Therapeutics, Inc have sold an estimated value of $725.74K and bought an estimated value of $37.07M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Carl Walkey, Senior Vice President,  Daron Evans, Chief Financial Officer,  and Joshua A Kazam, President & CEO .

Neoleukin Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1